Tower Research Capital (TRC)’s Insys Therapeutics, Inc. INSY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-10,157
| Closed | -$47K | – | 4703 |
|
|
2019
Q1 | $47K | Buy |
+10,157
| New | +$48.1K | ﹤0.01% | 1798 |
|
|
2018
Q4 | – | Sell |
-186
| Closed | -$2K | – | 4696 |
|
|
2018
Q3 | $2K | Sell |
186
-17,878
| -99% | -$143K | ﹤0.01% | 3528 |
|
|
2018
Q2 | $131K | Buy |
+18,064
| New | +$126K | 0.01% | 1271 |
|
|
2017
Q4 | – | Sell |
-3,578
| Closed | -$32K | – | 4335 |
|
|
2017
Q3 | $32K | Buy |
+3,578
| New | +$36.9K | ﹤0.01% | 2396 |
|
|
2017
Q1 | – | Sell |
-693
| Closed | -$6K | – | 4355 |
|
|
2016
Q4 | $6K | Buy |
693
+593
| +593% | +$6.7K | ﹤0.01% | 2998 |
|
|
2016
Q3 | $1K | Buy |
100
+53
| +113% | +$806 | ﹤0.01% | 3452 |
|
|
2016
Q2 | $1K | Sell |
47
-479
| -91% | -$6.98K | ﹤0.01% | 4293 |
|
|
2016
Q1 | $8K | Buy |
526
+90
| +21% | +$1.71K | ﹤0.01% | 2285 |
|
|
2015
Q4 | $12K | Buy |
436
+333
| +323% | +$9.23K | ﹤0.01% | 1942 |
|
|
2015
Q3 | $3K | Sell |
103
-1,860
| -95% | -$68.5K | ﹤0.01% | 3218 |
|
|
2015
Q2 | $70K | Buy |
1,963
+159
| +9% | +$4.95K | 0.01% | 1111 |
|
|
2015
Q1 | $52K | Buy |
1,804
+1,404
| +351% | +$37.1K | 0.01% | 1445 |
|
|
2014
Q4 | $8K | Sell |
400
-1,492
| -79% | -$29.5K | ﹤0.01% | 2386 |
|
|
2014
Q3 | $37K | Buy |
1,892
+1,270
| +204% | +$19.9K | ﹤0.01% | 1805 |
|
|
2014
Q2 | $10K | Sell |
622
-1,724
| -73% | -$27.9K | ﹤0.01% | 2396 |
|
|
2014
Q1 | $49K | Buy |
2,346
+2,046
| +682% | +$40.6K | 0.01% | 1113 |
|
|
2013
Q4 | $4K | Sell |
300
-1,983
| -87% | -$27.5K | ﹤0.01% | 3735 |
|
|
2013
Q3 | $27K | Sell |
2,283
-6,717
| -75% | -$55.1K | ﹤0.01% | 2464 |
|
|
2013
Q2 | $42K | Buy |
+9,000
| New | +$33K | ﹤0.01% | 1079 |
|
Other funds holding INSY
WS
Tower Research Capital (TRC)'s INSY Position: Q2 2019 in Review
Tower Research Capital (TRC) sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 10,157 shares — an estimated $47K sold.
Tower Research Capital (TRC) first reported a position in INSY in Q2 2013 and held it in 19 quarters. The position peaked at $131K in Q2 2018. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.
- Tower Research Capital (TRC) reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
- Tower Research Capital (TRC) sold 10,157 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $47K.
- Tower Research Capital (TRC) first reported a position in Insys Therapeutics, Inc. in Q2 2013 and held it in 19 quarters.
- Tower Research Capital (TRC)'s Insys Therapeutics, Inc. position peaked at $131K in Q2 2018.
- 16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.
Based on Tower Research Capital (TRC)'s 13F filing for Q2 2019, filed 13 Aug 2019.